Skip to content

Neuronetics STIM Change in AP

Change in AP at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
-$1.02M-1,221%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$3.46M+220%
CVRx, Inc. logo
CVRx, Inc.CVRX
-$834K-593%
Stereotaxis logo
StereotaxisSTXS
-$49K-106%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$2.2M+127%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
-$14.3M-377%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's change in AP?
Neuronetics (STIM) reported change in AP of $559K in Q1 2026.
How has Neuronetics's change in AP changed year-over-year?
Neuronetics's change in AP increased by 121.2% year-over-year, from -$2.64M to $559K.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.